Elon Musk

Goals

October 1, 2025

Love him or hate him, Elon Musk reached half a trillion dollars in net worth today. That’s quite a lot of zeros.

Road to 30 - Question 22

The Road to 30 Years: Question 22

October 1, 2025

We’re island hopping on the Hudson River on today’s installment of the Road to 30 Years. Keen listeners can hear the serene sound of Little Island’s windchimes in the background. Check out the full journey on www.pharmasalmanac.com.

Road to 30 - Question 21

The Road to 30 Years: Question 21

September 30, 2025

We’re back at FIT to talk about a different, but very similarly named, college, MIT, and the role it played in the foundations of our Nice Insight platform. Check out the full journey on www.pharmasalmanac.com.

RezonBio Logo

New Rezon Logo

September 30, 2025

Our team is happy to unveil the new RezonBio logo, along with their new website: www.rezonbio.com.

RezonBio Signage

The Sign is Up!

September 30, 2025

Excited for all the big changes for Polpharma and Rezon, and not all of them are about the new brand. This business has hired some of the best talent to drive growth, and will be led by the new CEO, Dr. Adriana Kiędzierska-Mencfeld

RezonBio Website

RezonBio Website

September 30, 2025

That’s Nice is pleased to be able to support the launch of a new biologics CDMO based in Poland. This business split from Polpharma Biologics, which will now focus exclusively on biosimilars.

Orange Cycling Shoes

Orange Every Time

September 30, 2025

Can’t ride a new bike without the proper footwear.

GSK at CPHI 2016

Memories of CPHI 2016

September 29, 2025

Throwback to Nigel and Russell at the booth we developed for GSK at CPHI 2016 in Frankfurt.

Road to 50 Throwback

Throwback: Road to 50 States

September 29, 2025

One of the most fun aspects of the Road to 50 States was all the people we met along the way who just wanted to be part of the action, like this father and son in New Orleans.

Trialmed Branding

Trialmed Branding

September 29, 2025

We are excited to support PPD’s Trialmed division in its mission to revolutionize clinical trials for sponsors and patients alike.

Update cookies preferences